The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
Open accessAbstract
The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and associated deaths, and represents a significant challenge to healthcare professionals and facilities. Individual countries have taken several prevention and containment actions to control the spread of infection, including measures to guarantee safety of both healthcare professionals and patients who are at increased risk of infection from COVID-19. Faecal microbiota transplantation (FMT) has a well-established role in the treatment of Clostridioides difficile infection. In the time of the pandemic, FMT centres and stool banks are required to adopt a workflow that continues to ensure reliable patient access to FMT while maintaining safety and quality of procedures. In this position paper, based on the best available evidence, worldwide FMT experts provide guidance on issues relating to the impact of COVID-19 on FMT, including patient selection, donor recruitment and selection, stool manufacturing, FMT procedures, patient follow-up and research activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“probiotics and fecal microbiota transplantation (FMT) could be used for the prevention and therapy of pulmonary diseases with widespread potential (33,34).”
From The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy (2021) · doi:10.3389/fonc.2021.720842 · cites this paper as [34]
In the citing paper
“Morerecently, donor stool screening has been updated to prevent the theoretical risk of COVID-19, 20 with satisfactory safety outcomes. 21”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [20]
In the citing paper
“More recently, the FDA released a similar alert after the start of the COVID-19 pandemic, 47 promptly followed by the definition of guidelines to prevent FMT-related transmission of SARS-CoV-2, 20 which has proved effective. 21”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Evidence for gastrointestinal infection of SARS-CoV-2
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.055 · Cited by 2,836
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Self-citationBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
Zhang, W., Du, R.-H., Li, B., Zheng, X.-S., Yang, X.-L., Hu, B., Wang, Y.-Y., Xiao, G.-F., Yan, B., Shi, Z.-L., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729071 · Cited by 1,799
Research works printed but not linked: 1
- Xiang, 2020, Antibody detection and dynamic characteristics in patients with COVID-19, Clin Infect Dis
Cited by
Antibiotics as Major Disruptors of Gut Microbiota
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 898
van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640
Self-citationFecal microbiota transplantation: current challenges and future landscapes
Yadegar, A., Bar-Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 351
Self-citationKey determinants of success in fecal microbiota transplantation: From microbiome to clinic
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331
Self-citationThe microbiota in cirrhosis and its role in hepatic decompensation
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 268
Metadata
- Authors
- Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., Zhang, F., Fischer, M., Costello, S. P., Keller, J. J., Masucci, L., van Prehn, J., Quaranta, G., Quraishi, M. N., Segal, J., Kao, D., Satokari, R., Sanguinetti, M., Tilg, H., Gasbarrini, A., & Cammarota, G.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Imperial College London (GB)
- Brown University (US)
- Finch Therapeutics (United States) (US)
- Leiden University Medical Center (NL)
- Chinese University of Hong Kong (HK)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Brigham and Women's Hospital (US)
- Inserm (FR)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Indiana University Indianapolis (US)
- Queen Elizabeth Hospital (AU)
- Netherlands Donor Feces Bank, Leiden University Medical Center, Leiden, The Netherlands
- St Mark's Hospital (GB)
- University of Alberta (CA)
- University of Helsinki (FI)
- Innsbruck Medical University (AT)
- Corresponding author
- Cammarota, Giovanni
- ORCID
- Ianiro, Gianluca
- Mullish, Benjamin H
- Kelly, Colleen R
- Kassam, Zain
- Kuijper, Ed J
- Ng, Siew C
- Iqbal, Tariq H
- Allegretti, Jessica R
- Bibbò, Stefano
- Sokol, Harry
- Zhang, Faming
- Fischer, Monika
- Costello, Samuel Paul
- Keller, Josbert J
- Masucci, Luca
- Quaranta, Gianluca
- Quraishi, Mohammed Nabil
- Segal, Jonathan
- Kao, Dina
- Satokari, Reetta
- Sanguinetti, Maurizio
- Tilg, Herbert
- Gasbarrini, Antonio
- Cammarota, Giovanni
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2020-07-03
- Volume
- 69
- Issue
- 9
- Pages
- 1555-1563
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC7456726
- OpenAlex
- W3038963949
- Cited by
- 147
- References
- 55
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 22 · 2023: 31 · 2022: 24 · 2021: 37 · 2020: 17
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Gut (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc)
- HAL (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion, cc-by-nc)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by-nc)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Funders
- The project was in part funded by the Catholic University of Rome, Line D-1 research funding. (Catholic University of Rome, Italy)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, COVID-19 pandemic, Clostridium difficile infection, stool bank, donor recruitment, donor selection, patient selection, patient follow-up
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Betacoronavirus, Change Management, COVID-19, SARS-CoV-2, Clostridium Infections, Gastroenterology, Humans, Pneumonia, Viral, Infection Control, Coronavirus Infections, Patient Selection, Risk Adjustment, Donor Selection, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. https://app.cochat.ai/papers/10.1136/gutjnl-2020-321829
- The paper
- Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., Zhang, F., Fischer, M., Costello, S. P., Keller, J. J., Masucci, L., van Prehn, J., Quaranta, G., Quraishi, M. N., Segal, J., . . . Cammarota, G. (2020). Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. https://doi.org/10.1136/gutjnl-2020-321829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.